Role of beta-blocker in Stroke outcome.
Not Applicable
Not yet recruiting
- Registration Number
- CTRI/2022/07/043879
- Lead Sponsor
- Prinicipal Investigator
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Consecutive patients with CT/MRI proven stroke within 3 days of ictus will be included
Exclusion Criteria
Stroke due to arteriovenous malformation, aneurysm, coagulopathy,
bleeding disorders, tumor, trauma, patients with hepatic or renal failure, pre-existing cardiac
failure, heart block, renal disease, liver disease, endocrinal disease, HIV, pregnancy,
lactation, and those on corticosteroids, norepinephrine, immunosuppressant, chemotherapy
and radiotherapy will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause mortalityTimepoint: One month
- Secondary Outcome Measures
Name Time Method 1. SIRS, Pneumonia <br/ ><br>2. Functional outcomeTimepoint: 1. 2 weeeks <br/ ><br>2. 3 months